Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2009 (2009), Article ID 175216, 7 pages
http://dx.doi.org/10.1155/2009/175216
Review Article

The Use of N-Terminal-Pro-BNP in Preterm Infants

1Department of Neonatology, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8
2Department of Postgraduate Research, School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland
3Department of Neonatology, National Maternity Hospital, Dublin 2, Ireland
4Department of Neonatology, Lady's Children's Hospital, Crumlin, Dublin 12, Ireland

Received 9 September 2009; Accepted 16 November 2009

Academic Editor: Peter Oishi

Copyright © 2009 Afif EL-Khuffash and Eleanor Molloy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Hunt, T. G. Yandle, M. G. Nicholls, A. M. Richards, and E. A. Espiner, “The amino-terminal portion of Pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma,” Biochemical and Biophysical Research Communications, vol. 214, no. 3, pp. 1175–1183, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Maack, “Receptors of atrial natriuretic factor,” Annual Review of Physiology, vol. 54, pp. 11–27, 1992. View at Google Scholar · View at Scopus
  3. R. Witthaut, “Science review: natriuretic peptides in critical illness,” Critical Care, vol. 8, no. 5, pp. 342–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Abassi, T. Karram, S. Ellaham, J. Winaver, and A. Hoffman, “Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance,” Pharmacology and Therapeutics, vol. 102, no. 3, pp. 223–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer, “Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure,” Heart, vol. 91, no. 5, pp. 606–612, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. W. Troughton, C. M. Frampton, T. G. Yandle, E. A. Espiner, M. G. Nicholls, and A. M. Richards, “Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations,” The Lancet, vol. 355, no. 9210, pp. 1126–1130, 2000. View at Google Scholar · View at Scopus
  7. M. M. Redfield, R. J. Rodeheffer, S. J. Jacobsen, D. W. Mahoney, K. R. Bailey, and J. C. Burnett Jr., “Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study,” Circulation, vol. 109, no. 25, pp. 3176–3181, 2004. View at Google Scholar · View at Scopus
  8. I. S. Anand, L. D. Fisher, Y.-T. Chiang et al., “Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT),” Circulation, vol. 107, no. 9, pp. 1278–1283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Westerlind, H. Wahlander, G. Lindstedt, P.-A. Lundberg, and D. Holmgren, “Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy,” Acta Paediatrica, vol. 93, no. 3, pp. 340–345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Nir, B. Bar-Oz, Z. Perles, R. Brooks, A. Korach, and A. J. Rein, “N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases,” Acta Paediatrica, vol. 93, no. 5, pp. 603–607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Koch, S. Zink, and H. Singer, “B-type natriuretic peptide in paediatric patients with congenital heart disease,” European Heart Journal, vol. 27, no. 7, pp. 861–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Nasser, Z. Perles, A. J. Rein, and A. Nir, “NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis,” Pediatric Cardiology, vol. 27, no. 1, pp. 87–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Cohen, C. Springer, A. Avital et al., “Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress?” Pediatrics, vol. 115, pp. 1347–1350, 2005. View at Google Scholar
  14. P. Gessler, W. Knirsch, B. Schmitt, V. Rousson, and A. von Eckardstein, “Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery,” Journal of Pediatrics, vol. 148, no. 3, pp. 372–376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Carmona, P. H. Manso, W. V. A. Vicente, M. Castro, and A. P. C. P. Carlotti, “Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: a multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I,” Cytokine, vol. 42, no. 3, pp. 317–324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Shalev, A. Nir, and E. Granot, “Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage,” Pediatric Transplantation, vol. 9, no. 6, pp. 718–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. G. Cowley, J. D. Bradley, and R. E. Shaddy, “B-type natriuretic peptide levels in congenital heart disease,” Pediatric Cardiology, vol. 25, no. 4, pp. 336–340, 2004. View at Google Scholar · View at Scopus
  18. M. Weber, R. Arnold, M. Rau et al., “Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease,” European Heart Journal, vol. 26, no. 10, pp. 1023–1030, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. W. E. Hopkins, Z. Chen, N. K. Fukagawa, C. Hall, H. J. Knot, and M. M. LeWinter, “Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion,” Circulation, vol. 109, no. 23, pp. 2872–2877, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. T. S. Mir, S. Marohn, S. Laer, M. Eiselt, O. Grollmus, and J. Weil, “Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure,” Pediatrics, vol. 110, no. 6, article e76, 2002. View at Google Scholar · View at Scopus
  21. T. S. Mir, R. Laux, H. H. Hellwege et al., “Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth,” Pediatrics, vol. 112, no. 4, pp. 896–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Nir, A. Lindinger, M. Rauh et al., “NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies,” Pediatric Cardiology, vol. 30, no. 1, pp. 3–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Bar-Oz, A. Lev-Sagie, I. Arad, L. Salpeter, and A. Nir, “N-termonal pro-B-type natriuretic paptide concentrations in mothers just before delivery, in cord blood, and in newborns,” Clinical Chemistry, vol. 51, no. 5, pp. 926–927, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. El-Khuffash and E. J. Molloy, “Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 92, pp. F320–F324, 2007. View at Google Scholar
  25. A. EL-Khuffash, P. G. Davis, K. Walsh, and E. J. Molloy, “Cardiac troponin T and N-terminal-pro-B type natriuretic peptide reflect myocardial function in preterm infants,” Journal of Perinatology, vol. 28, no. 7, pp. 482–486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. W. F. Friedman and S. E. Kirkpatrick, “In situ physiological study of the developing heart,” Recent Advances in Studies on Cardiac Structure and Metabolism, vol. 5, pp. 497–504, 1975. View at Google Scholar · View at Scopus
  27. S. Noori and I. Seri, “Pathophysiology of newborn hypotension outside the transitional period,” Early Human Development, vol. 81, no. 5, pp. 399–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. El-Khuffash, M. Higgins, K. Walsh, and E. J. Molloy, “Quantitative assessment of the degree of ductal steal using celiac artery blood flow to left ventricular output ratio in preterm infants,” Neonatology, vol. 93, no. 3, pp. 206–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. El-Khuffash, D. Barry, K. Walsh, P. G. Davis, and E. J. Molloy, “Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 93, no. 6, pp. f407–f412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Schwachtgen, M. Herrmann, T. Georg, P. Schwarz, N. Marx, and A. Lindinger, “Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children,” Zeitschrift fur Kardiologie, vol. 94, no. 6, pp. 399–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Hammerer-Lercher, E. Neubauer, S. Muller, O. Pachinger, B. Puschendorf, and J. Mair, “Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction,” Clinica Chimica Acta, vol. 310, no. 2, pp. 193–197, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Bakker, I. Gies, B. Slavenburg, O. Bekers, T. Delhaas, and M. van Dieijen-Visser, “Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood,” Clinical Chemistry, vol. 50, no. 12, p. 2465, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Rauh and A. Koch, “Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children,” Clinical Chemistry, vol. 49, no. 9, pp. 1563–1564, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. S. J. Soldin, O. P. Soldin, A. J. Boyajian, and M. S. Taskier, “Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals,” Clinica Chimica Acta, vol. 366, no. 1-2, pp. 304–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. F. El-Khuffash, M. Amoruso, M. Culliton, and E. J. Molloy, “N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 92, no. 5, pp. F421–F422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Nuntnarumit, A. Khositseth, and P. Thanomsingh, “N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants,” Journal of Perinatology, vol. 29, no. 2, pp. 137–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Farombi-Oghuvbu, T. Matthews, P. D. Mayne, H. Guerin, and J. D. Corcoran, “N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 93, no. 4, pp. F257–F260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Ramakrishnan, Y. M. Heung, J. Round, T. P. Morris, P. Collinson, and A. F. Williams, “Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants,” Acta Paediatrica, vol. 98, no. 8, pp. 1254–1259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. B. M. Choi, K. H. Lee, B. L. Eun et al., “Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants,” Pediatrics, vol. 115, pp. e255–e261, 2005. View at Google Scholar
  40. H. Holmstrom, C. Hall, and E. Thaulow, “Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants,” Acta Paediatrica, vol. 90, no. 2, pp. 184–191, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Holmstrom and T. Omland, “Natriuretic peptides as markers of patent ductus arteriosus in preterm infants,” Clinical Science, vol. 103, no. 1, pp. 79–80, 2002. View at Google Scholar · View at Scopus
  42. S. Sanjeev, M. Pettersen, J. Lua, R. Thomas, S. Shankaran, and T. L'Ecuyer, “Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates,” Journal of Perinatology, vol. 25, no. 11, pp. 709–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. P. A. Flynn, R. L. Da Graca, P. A. M. Auld, M. Nesin, and C. S. Kleinman, “The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates,” Journal of Pediatrics, vol. 147, no. 1, pp. 38–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Gagliardi, A. Cavazza, A. Brunelli et al., “Assessing mortality risk in very low birthweight infants: a comparison of CRIB, CRIB-II, and SNAPPE-II,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 89, no. 5, pp. F419–F422, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. P. J. McNamara and A. Sehgal, “Towards rational management of the patent ductus arteriosus: the need for disease staging,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 92, no. 6, pp. F424–F427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. K.-I. Tomaru, M. Arai, T. Yokoyama et al., “Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 6, pp. 649–659, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Witthaut, C. Busch, P. Fraunberger et al., “Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction,” Intensive Care Medicine, vol. 29, no. 10, pp. 1696–1702, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Rudiger, S. Gasser, M. Fischler, T. Hornemann, A. Von Eckardstein, and M. Maggiorini, “Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure,” Critical Care Medicine, vol. 34, no. 8, pp. 2140–2144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Brueckmann, G. Huhle, S. Lang et al., “Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis,” Circulation, vol. 112, no. 4, pp. 527–534, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Roch, J. Allardet-Servent, P. Michelet et al., “NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients,” Critical Care Medicine, vol. 33, no. 5, pp. 1001–1007, 2005. View at Publisher · View at Google Scholar · View at Scopus